Zenas BioPharma, Inc.
ZBIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $115,565 | $44,006 | $196,554 | $319,742 |
| Short-Term Investments | $175,319 | $229,273 | $115,825 | $31,024 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $5,758 | $5,324 | $5,428 | $5,157 |
| Total Curr. Assets | $296,642 | $278,603 | $317,807 | $355,923 |
| Property Plant & Equip (Net) | $857 | $1,071 | $1,276 | $1,189 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $10,717 | $1,614 | $1,835 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $13,802 | $11,797 | $12,848 | $12,856 |
| Total NC Assets | $25,376 | $14,482 | $15,959 | $14,045 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $322,018 | $293,085 | $333,766 | $369,968 |
| Liabilities | – | – | – | – |
| Payables | $6,444 | $7,931 | $20,018 | $17,136 |
| Short-Term Debt | $618 | $793 | $908 | $785 |
| Tax Payable | $0 | $0 | $5 | $211 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $45,359 | $44,520 | $28,201 | $39,160 |
| Total Curr. Liab. | $52,421 | $53,244 | $49,132 | $57,292 |
| LT Debt | $180 | $215 | $317 | $218 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $72,989 | $0 | $0 | $0 |
| Total NC Liab. | $73,169 | $215 | $317 | $218 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $798 | $1,008 | $1,225 | $1,003 |
| Total Liabilities | $125,590 | $53,459 | $49,449 | $57,510 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $4 | $4 | $4 | $4 |
| Retained Earnings | -$524,686 | -$473,187 | -$420,964 | -$387,391 |
| AOCI | -$69 | -$94 | $141 | $194 |
| Other Equity | $721,179 | $712,903 | $705,136 | $699,651 |
| Total Equity | $196,428 | $239,626 | $284,317 | $312,458 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $322,018 | $293,085 | $333,766 | $369,968 |
| Net Debt | -$114,767 | -$42,998 | -$195,329 | -$318,739 |